09 Jun 2021
NetTargets has partnered with Cellkey, which provides a cutting-edge AI-based glycopeptide analysis platform, to discover biomarkers for early detection and treatment of cancer.
Jaehong Shin, CDO of NetTargets will present at Korean American Society in Biotech and Pharmaceuticals (KASBP) eSymposium on June 4, 2021 about computational approaches for early phase drug discovery research in the age of AI.
01 Apr 2021
AI Times recognized NetTargets as one of the notable AI startups in biopharmaceuticals in 2021.
05 Jan 2021
We are pleased to be one of top 10 biotech startsups in APAC 2020 selected by Startupcity magazine.
30 Dec 2020
Our next news and events are coming soon